Academic Content and Language Evaluation of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3684)
All Articles published online
|
Publishing Process of This Article
|
Nov 26, 2021 (publication date) through Apr 18, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Grillo TG, Almeida LR, Beraldo RF, Marcondes MB, Queiróz DAR, da Silva DL, Quera R, Baima JP, Saad-Hossne R, Sassaki LY. Heart failure as an adverse effect of infliximab for Crohn's disease: A case report and review of the literature. World J Clin Cases 2021; 9(33): 10382-10391 [PMID: 34904114 DOI: 10.12998/wjcc.v9.i33.10382] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v9/i33/10382.htm |
| Number | Citing Articles |
| 1 |
Thais Gagno Grillo, Caroline Ferreira da Silva Mazeto Pupo Silveira, Ana Elisa Valencise Quaglio, Renata de Medeiros Dutra, Julio Pinheiro Baima, Silmeia Garcia Zanati Bazan, Ligia Yukie Sassaki. Acute heart failure as an adverse event of tumor necrosis factor inhibitor therapy in inflammatory bowel disease: A review of the literature. World Journal of Cardiology 2023; 15(5): 217-228 doi: 10.4330/wjc.v15.i5.217
|
| 2 |
Sanjib Mondal, Prabal Barman, Pandiarajan Vignesh. Cardiovascular Abnormalities in Juvenile Dermatomyositis: A Scoping Review for the Clinical Rheumatologists. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.827539
|
| 3 |
Yuxiong Jiang, Youdong Chen, Qian Yu, Yuling Shi. Biologic and Small-Molecule Therapies for Moderate-to-Severe Psoriasis: Focus on Psoriasis Comorbidities. BioDrugs 2023; 37(1): 35 doi: 10.1007/s40259-022-00569-z
|
| 4 |
Malcolm Irani, Bincy Abraham. Choosing Therapy for Moderate to Severe Crohn’s Disease. Journal of the Canadian Association of Gastroenterology 2024; 7(1): 1 doi: 10.1093/jcag/gwad023
|
| 5 |
Mohammad Reza Hatamnejad, Mersedeh Karvandi, Fateme Jodatfar, Nastaran Ebrahimi, Fatemeh Shojaeian, Shaghayegh Baradaran Ghavami, Hedieh Balaii, Mahdi Moeeni, Mohsen Rajabnia, Shabnam Shahrokh, Hamid Asadzadeh Aghdaei. Evaluation of adalimumab effects on left ventricle performance by echocardiography indexes among patients with immunosuppressant refractory ulcerative colitis. Frontiers in Medicine 2023; 9 doi: 10.3389/fmed.2022.1008711
|
| 6 |
|
| 7 |
Elżbieta Lazar-Poloczek, Ewa Romuk, Wojciech Jacheć, Wiktoria Stanek, Bartosz Stanek, Monika Szołtysik, Tomasz Techmański, Maja Hasterok, Celina Wojciechowska. Levels of TNF-α and Soluble TNF Receptors in Normal-Weight, Overweight and Obese Patients with Dilated Non-Ischemic Cardiomyopathy: Does Anti-TNF Therapy Still Have Potential to Be Used in Heart Failure Depending on BMI?. Biomedicines 2022; 10(11): 2959 doi: 10.3390/biomedicines10112959
|
| 8 |
Lindsey Sellers Coppiano, Dianne May. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. Side Effects of Drugs Annual 2022; 44: 379 doi: 10.1016/bs.seda.2022.09.012
|
| 9 |
Chendong Peng, Yuang Jiang, Xianhong Ou, Lei Liao, Chengying Yang, Qiao Zhou, Yan Wei, Lijia Chang, Xinrong Fan. Novel XIAP mutation with early-onset Crohn’s disease complicated with acute heart failure: a case report. BMC Cardiovascular Disorders 2023; 23(1) doi: 10.1186/s12872-023-03386-6
|